Skin conditions (dermatitis, eczema, psoriasis) Board decisions

The veteran withdrew the appeal for service connection claims related to several skin conditions and foot condition.

The Board remands the claims for service connection for a skin condition and genitourinary condition to obtain additional medical evidence.

The Board granted an increased initial rating of 60 percent for tinea pedis, as the Veteran's condition required constant or near-constant systemic therapy over the entire appeal period.

The Board remands the claim for a compensable disability rating for pseudofolliculitis barbae (PFB) to ensure an adequate VA examination is conducted, particularly during a flare-up.

The Board remands the issues of an initial rating greater than 10 percent for pseudofolliculitis barbae (PFB) and a separate rating for painful scars associated with PFB due to insufficient evidence regarding the severity and progression of the condition.

The Board granted service connection for a skin disability, to include dermatitis, lichen simplex chronicus, and seborrheic keratosis, based on the Veteran's in-service rashes and continuous symptoms since service.

The Board denied increased ratings for several service-connected conditions and granted service connection for a few others, including tinea pedis, bilateral dry eye syndrome, right shoulder disability, cervical spine disability, left knee disability (secondary), right knee disability (secondary), and right ankle disability (secondary).

The appeal regarding whether the finding of clear and unmistakable error (CUE) in a June 14, 2019, rating decision that assigned two separate evaluations of 10 percent as a skin disability and 30 percent as facial scarring for the Veteran's service-connected pseudofolliculitis barbae (PFB) was proper, is denied.

The Board granted service connection for bilateral tinnitus, chronic sinusitis, and an acquired psychiatric disorder. The claims for left ankle pain, right ankle pain, pseudofolliculitis barbae, and radiculopathy of the lower extremities were denied.

The Board granted service connection for multiple conditions, including adjustment disorder with anxiety and depressed mood, GERD, contact dermatitis, left ankle gout, degenerative changes of the lumbosacral spine, left knee meniscal tear and gout, left big toe gout, left elbow gout, status post cervical fusion, and sleep apnea, as they are related to active duty training (ACDUTRA).

The Board remands the claims for service connection for lumbosacral strain, right ankle tendonitis, and dermatitis to correct duty-to-assist errors.

The Board granted service connection for tinnitus and dermatitis, finding that both conditions are related to the Veteran's active duty service.

The Board granted earlier effective dates of August 5, 2021, for the grant of service connection for sinusitis and dermatitis under the PACT Act.

The Board denied the Veteran's claims for increased ratings for tinnitus, atrioventricular (AV) block, left knee patellofemoral pain syndrome, and tinea pedis.

The Board granted the Veteran's appeal for an annual clothing allowance for 2021 due to damage caused by Clindamycin Benzoyl Peroxide 1 to 3 percent topical gel used to treat a service-connected disability.

The Board denied a compensable rating for tinea unguium and restored the 20 percent disability evaluation for chronic pain syndrome.

The Board granted service connection for nummular eczema, finding that new and relevant evidence was submitted and the Veteran's symptoms were related to his in-service skin conditions.

The Board denied service connection for acne and remanded several claims, while granting a 10 percent rating for the headache condition from April 11, 2022, to May 5, 2023.

The Board denied a compensable rating for pseudofolliculitis barbae but granted service connection for migraines.

The Board remands the claim for an increased initial rating for a skin disability, including chronic dermatitis, tinea pedis, xerosis and hyperkeratosis, to obtain additional medical evidence regarding systemic therapy and the degree of involvement of nonservice-connected disabilities.